Regain your health

Psoriasis, how to treat it

Tractament de la psoriasi a Vall d'Hebron

Currently, there are different treatments that can alleviate the signs and symptoms, and, in most cases, cure skin lesions. The dermatology specialist decides the most appropriate treatment for each patient, depending on the type of psoriasis, its location, its extent and severity and the characteristics of the person suffering from it.

Description

There are three types of treatment:

  • Topical. Creams, shampoos and lotions that are applied directly to the skin.
  • Phototherapy. Treatment with ultraviolet light A (UVA) or B (UVB rays), usually administered 2-3 times a week for 2-3 months.
  • Systemic or generalised. Drugs administered orally (pills) or injected. They must be monitored strictly by means of blood tests, to check for possible adverse effects
   
Educació sanitària relacionades
Consells de salut per a persones amb psoriasi a Vall d'Hebron
Health tips for patients with psoriasis
3288
 
Noticies y activitats relacionades
01 Dec
From genome to precision medicine in pediatric movement disorders
Hora :

From 8 to 19 h.
30 Nov
From genome to precision medicine in pediatric movement disorders
Hora :

De 8 a 19 h.
28 Sep
II Jornada Trastorno Espectro Alcohólico Fetal
Hora :

From 9 to 15 h.
27 Sep
II Jornada Trastorno Espectro Alcohólico Fetal
Hora :

From 9 to 15 h.
21 Sep
Reunión anual de la Sociedad Española de Cardiología. Sección de Cardiología Geriátrica
Hora :

From 8.30 to 18.00 h.
Vall d’Hebron and Daniel Bravo Foundation open the new Cystic Fibrosis Unit, a European pioneer 04/07/2018
Juvenile ALS is a very singular and rare type of Amyotrophic Lateral Sclerosis 21/06/2018
recerca, nanomedicina, vhir
A new European project awarded to the CIBBIM-Nanomedicine of the VHIR converts the Vall d'Hebron Campus into the health institution with the most active research projects in Nanomedicine of Europe 26/04/2018
April, Fabry disease awareness month 25/04/2018
recerca, assaigs clinics, vhio, vhir, conveni
Campus Vall d'Hebron signs a Prime Site Agreement with IQVIA, the world's largest clinical trial management company 24/04/2018